Dawn M. Cleaver

487 total citations
8 papers, 326 citations indexed

About

Dawn M. Cleaver is a scholar working on Dermatology, Small Animals and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Dawn M. Cleaver has authored 8 papers receiving a total of 326 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Dermatology, 3 papers in Small Animals and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Dawn M. Cleaver's work include Dermatology and Skin Diseases (4 papers), Veterinary Oncology Research (3 papers) and Ocular Infections and Treatments (2 papers). Dawn M. Cleaver is often cited by papers focused on Dermatology and Skin Diseases (4 papers), Veterinary Oncology Research (3 papers) and Ocular Infections and Treatments (2 papers). Dawn M. Cleaver collaborates with scholars based in United States. Dawn M. Cleaver's co-authors include Michael Stegemann, J. A. WREN, Kelly F. Walsh, Vickie L. King, Joseph F. Boucher, David Martín, Margaret E. Gruen, B. Duncan X. Lascelles, Csilla Becskei and V. Michael Lane and has published in prestigious journals such as Journal of the American Veterinary Medical Association, Journal of Veterinary Internal Medicine and Veterinary Dermatology.

In The Last Decade

Dawn M. Cleaver

8 papers receiving 304 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dawn M. Cleaver United States 8 172 101 81 49 45 8 326
Kelly F. Walsh United States 6 212 1.2× 130 1.3× 67 0.8× 33 0.7× 50 1.1× 8 339
Nobutaka YASUDA Japan 7 61 0.4× 67 0.7× 43 0.5× 16 0.3× 250 5.6× 12 368
C Virchow Switzerland 8 42 0.2× 144 1.4× 92 1.1× 11 0.2× 83 1.8× 51 411
J.‐M. Ovigne United Kingdom 7 172 1.0× 41 0.4× 15 0.2× 26 0.5× 276 6.1× 9 389
E. J. Feuerman Israel 15 175 1.0× 35 0.3× 20 0.2× 38 0.8× 100 2.2× 60 571
Mayra Ianhez Brazil 13 217 1.3× 27 0.3× 11 0.1× 11 0.2× 48 1.1× 36 385
Passara Jongkhajornpong Thailand 12 54 0.3× 37 0.4× 10 0.1× 63 1.3× 27 0.6× 38 417
Annamaria Offidani Italy 12 191 1.1× 45 0.4× 8 0.1× 7 0.1× 57 1.3× 33 367
Jimena Perez-Lloret United Kingdom 8 30 0.2× 49 0.5× 32 0.4× 14 0.3× 248 5.5× 10 452
Karin Einsle Switzerland 5 30 0.2× 105 1.0× 39 0.5× 13 0.3× 199 4.4× 6 349

Countries citing papers authored by Dawn M. Cleaver

Since Specialization
Citations

This map shows the geographic impact of Dawn M. Cleaver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dawn M. Cleaver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dawn M. Cleaver more than expected).

Fields of papers citing papers by Dawn M. Cleaver

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dawn M. Cleaver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dawn M. Cleaver. The network helps show where Dawn M. Cleaver may publish in the future.

Co-authorship network of co-authors of Dawn M. Cleaver

This figure shows the co-authorship network connecting the top 25 collaborators of Dawn M. Cleaver. A scholar is included among the top collaborators of Dawn M. Cleaver based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dawn M. Cleaver. Dawn M. Cleaver is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
2.
Gruen, Margaret E., et al.. (2021). Frunevetmab, a felinized anti-nerve growth factor monoclonal antibody, for the treatment of pain from osteoarthritis in cats. Journal of Veterinary Internal Medicine. 35(6). 2752–2762. 22 indexed citations
3.
Cleaver, Dawn M., et al.. (2015). Long‐term compassionate use of oclacitinib in dogs with atopic and allergic skin disease: safety, efficacy and quality of life. Veterinary Dermatology. 26(3). 171–171. 65 indexed citations
4.
5.
WREN, J. A., Dawn M. Cleaver, David Martín, et al.. (2013). Efficacy and safety of oclacitinib for the control of pruritus and associated skin lesions in dogs with canine allergic dermatitis. Veterinary Dermatology. 24(5). 479–479. 89 indexed citations
6.
Six, Robert H., Dawn M. Cleaver, Judith A. Cherni, et al.. (2009). Effectiveness and safety of cefovecin sodium, an extended-spectrum injectable cephalosporin, in the treatment of cats with abscesses and infected wounds. Journal of the American Veterinary Medical Association. 234(1). 81–87. 7 indexed citations
7.
Six, Robert H., Dawn M. Cleaver, T. L. Skogerboe, et al.. (2008). Efficacy and safety of cefovecin in treating bacterial folliculitis, abscesses, or infected wounds in dogs. Journal of the American Veterinary Medical Association. 233(3). 433–439. 18 indexed citations
8.
Lane, V. Michael, Lisle W. George, & Dawn M. Cleaver. (2006). Efficacy of tulathromycin for treatment of cattle with acute ocular Moraxella bovis infections. Journal of the American Veterinary Medical Association. 229(4). 557–561. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kelly F. Walsh Breakdown of academic impact, for papers by Nobutaka YASUDA Breakdown of academic impact, for papers by C Virchow Breakdown of academic impact, for papers by J.‐M. Ovigne Breakdown of academic impact, for papers by E. J. Feuerman Breakdown of academic impact, for papers by Mayra Ianhez Breakdown of academic impact, for papers by Passara Jongkhajornpong Breakdown of academic impact, for papers by Annamaria Offidani Breakdown of academic impact, for papers by Jimena Perez-Lloret Breakdown of academic impact, for papers by Karin Einsle
Rankless by CCL
2026